MRNA US60770K1079

Report

Delayed Nasdaq - 06/16 04:00:00 pm
197.84	USD		-1.86%

06/16

CureVac fails in pivotal COVID-19 vaccine trial with 47% efficacy

06/16

MODERNA : Manitoba to expand its COVID-19 vaccine effort with large Moderna supply

06/16

MODERNA : U.S. administers 312.9 mln doses of COVID-19 vaccines - CDC

Summary

Quotes 5-day view Delayed Quote.

Delayed Nasdaq

06/10/2021	06/11/2021	06/14/2021	06/15/2021	06/16/2021	Date
217(c)	218.85(c)	207.41(c)	201.59(c)	197.84(c)	Last
11 763 149	5 576 026	11 743 700	6 786 260	7 264 747	Volume
-0.20%	+0.85%	-5.23%	-2.81%	-1.86%	Change

More quotes

Financials (USD)

Sales 2021	18 664 M - -
Net income 2021	10 397 M - -
Net cash position 2021	11 520 M - -
P/E ratio 2021	8,02x
Yield 2021	-

Sales 2022	15 893 M - -
Net income 2022	7 759 M - -
Net cash position 2022	20 906 M - -
P/E ratio 2022	11,2x
Yield 2022	-

Capitalization	79 438 M 79 438 M -
EV / Sales 2021	3,64x
EV / Sales 2022	3,68x
Nbr of Employees	1 300
Free-Float	90,3%

More Financials

Company

Moderna, Inc. is a biotechnology company specialized in research and development of therapeutics and vaccines for infectious, autoimmune and cardiovascular diseases. Turnover per type of income can be broken down as follows: - Collaboration revenue (79.8%); - Grant revenue (20.2%). At the end of 2019, the group possessed a portfolio of 6 development candidates in clinical studies, with three in phase II and...

Sector

Biotechnology & Medical Research

Calendar

08/11

Earnings Release

More about the company

Ratings of Moderna, Inc.

Trading Rating :

Investor Rating :

ESG Refinitiv :

C-

More Ratings

All news about MODERNA, INC.

06/16	CureVac fails in pivotal COVID-19 vaccine trial with 47% efficacy	RE
06/16	MODERNA : Manitoba to expand its COVID-19 vaccine effort with large Moderna sup..	AQ
06/16	MODERNA : U.S. administers 312.9 mln doses of COVID-19 vaccines - CDC	RE
06/16	MODERNA : U.S. CDC Says 146,456,124 Individuals Have Been Fully Vaccinated Agai..	RE
06/16	MODERNA : COVID-19 vaccine prevented 95% of new infections after one dose in st..	AQ
06/16	WALL STREET STOCK EXCHANGE : How yesterday’s data could affect Fed policy
06/16	MODERNA : To Supply Further 200 Million COVID-19 Vaccine Doses To US	MT
06/16	MODERNA : Gets Order of 200 Million More Doses of Its COVID-19 Vaccine From US ..	MT
06/16	MODERNA : U.S. Government Purchases Additional 200 Million Doses of Moderna's C..	BU
06/16	UK Vaccination Rate Slows Down On Shortage Of Pfizer Jabs	MT
06/15	US, EU Vow to Provide COVID-19 Vaccine to Two-Thirds of World's Population by..	MT
06/15	MODERNA : U.S. administers nearly 311.9 mln doses of COVID-19 vaccines - CDC	RE
06/15	MODERNA : U.S. CDC Says Administered 311,886,674 Doses Of COVID-19 Vaccine As O..	RE
06/15	Moderna Signs COVID-19 Vaccine Distribution Deal In UAE	MT
06/15	MODERNA : Taps Magenta Investments As UAE Distributor For COVID-19 Vaccine	MT

More news

News in other languages on MODERNA, INC.

06/16	CORONA-BLOG/Spahn erwartet Erstimpfung aller Impfwilligen Anfang August
06/16	MODERNA : Washington commande 200 millions de doses en plus
06/16	MODERNA : Washington achète 200 millions de doses supplémentaires de son vaccin
06/16	WALL STREET STOCK EXCHANGE : Cómo podrían afectar los datos de ayer a la polític..
06/16	Les valeurs à suivre aujourd'hui à Wall Street Mercredi 16 juin 2021

More news

Analyst Recommendations on MODERNA, INC.

06/07	MODERNA : Piper Sandler Adjusts Moderna's Price Target to $246 From $231, Maint..	MT
05/07	MODERNA : Chardan Adjusts Price Target on Moderna to $188 From $182, Maintains ..	MT
05/07	MODERNA : JPMorgan Adjusts Moderna's Price Target to $127 From $121, Maintains ..	MT

More recommendations

Stock Trading Strategies

	MODERNA, INC. - 2020
The beginning of the move

BUY

More Stock Trading Analysis

Provided by Scoopnest.com

Analysis

Samsung BioLogics shares ease after jumping on vaccine deal